Centro Emofilia E Trombosi Angelo Bianchi Bonomi
- Address
- Via Pace 9, 20122 Milan, Italy
Centro Emofilia E Trombosi Angelo Bianchi Bonomi
The Centro Emofilia E Trombosi Angelo Bianchi Bonomi specializes in research and treatment of inherited bleeding and clotting disorders. The center focuses on advancing therapeutic strategies for patients with rare coagulation disorders, particularly those requiring surgical intervention or facing high-risk clinical situations.
- Congenital antithrombin deficiency management and thromboprophylaxis
- Perioperative care for patients with inherited coagulation disorders
- Prevention of thrombotic and thromboembolic events in high-risk populations
The center's research efforts include evaluating novel therapeutic approaches for congenital antithrombin deficiency, a rare inherited condition that increases the risk of dangerous blood clots. Their clinical trials investigate the efficacy of antithrombin replacement therapy in protecting patients during surgical procedures and delivery, with particular emphasis on preventing thrombotic and thromboembolic events in this vulnerable patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Octapharma AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro Emofilia E Trombosi Angelo Bianchi Bonomi
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Antithrombin III Human in Patients with Congenital Antithrombin Deficiency Undergoing Surgical Procedures or Parturition | Octapharma AG | Phase III | Recruiting | Feb 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Antithrombin Iii Human | 1 | Unknown | 2023-02-14 | 2023-02-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.